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Abstract
Background: Gastrointestinal microbial communities are diverse and are composed of both beneficial and
pathogenic groups. Prebiotics, such as digestion-resistant fibers, influence the composition of gut microbiota, and
can contribute to the improvement of host health. The red seaweed Chondrus crispus is rich in dietary fiber and
oligosaccharides, however its prebiotic potential has not been studied to date.
Methods: Prebiotic effects were investigated with weaning rats fed a cultivated C. crispus-supplemented diet.
Comparison standards included a fructo-oligo-saccharide (FOS) diet and a basal diet. The colonic microbiome was
profiled with a 16S rRNA sequencing-based Phylochip array. Concentrations of short chain fatty acids (SCFAs) in the
feacal samples were determined by gas chromatography with a flame ionization detector (GC-FID) analysis.
Immunoglobulin levels in the blood plasma were analyzed with an enzyme-linked immunosorbent assay (ELISA).
Histo-morphological parameters of the proximal colon tissue were characterized by hematoxylin and eosin (H&E)
staining.
Results: Phylochip array analysis indicated differing microbiome composition among the diet-supplemented
and the control groups, with the C. crispus group (2.5 % supplementation) showing larger separation from the
control than other treatment groups. In the 2.5 % C. crispus group, the population of beneficial bacteria such as
Bifidobacterium breve increased (4.9-fold, p = 0.001), and the abundance of pathogenic species such as Clostridium
septicum and Streptococcus pneumonia decreased. Higher concentrations of short chain fatty acids (i.e., gut microbial
metabolites), including acetic, propionic and butyric acids, were found in faecal samples of the C. crispus-fed rats.
Furthermore, both C. crispus and FOS supplemented rats showed significant improvements in proximal colon
histo-morphology . Higher faecal moisture was noted in the 2.5 % C. crispus group, and elevated plasma
immunoglobulin (IgA and IgG) levels were observed in the 0.5 % C. crispus group, as compared to the basal
feed group.
Conclusions: The results suggest multiple prebiotic effects, such as influencing the composition of gut
microbial communities, improvement of gut health and immune modulation in rats supplemented with
cultivated C. crispus.
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Background
Mammalian gastrointestinal (GI) tracts are colonized by
a large number of beneficial and pathogenic microbes.
There are up to 1012 bacteria per gram of digesta in the
colon, the most intensively colonized portion of the GI
tract [1]. Beneficial gut bacteria (i.e., probiotics), such as
Bifidobacterium spp. and Lactobacillus spp. promote ani-
mal and human health by providing nutritional metabo-
lites, such as short chain fatty acids, through selective
fermentation of digestion-resistant carbohydrates [2].
The digestion-resistant carbohydrates (i.e., prebiotics),
serve as a nutrient source for probiotic bacteria. Dietary
supplementation of prebiotics and/or probiotics can help
to maintain a favorable ratio of the beneficial to harmful
bacteria in the host gut, allowing competition to favor
beneficial groups [2, 3].
Research shows that consumption of prebiotics and/or
probiotics results in multiple health benefits including
improving consistency and frequency of the stool [4, 5],
preventing allergic diseases [6–8], regulating immunity
[9–11] and decreasing the risks of cancers [12, 13] and
obesity [8, 12]. For example, when children with food
allergy-related severe atopic eczema were fed Lactobacil-
lus rhamnosus and Bifidobacterium lactis, they showed
significant improvement in clinical symptoms, as com-
pared to the placebo group [14, 15]. Likewise, in
formula-fed infants, IgA immune response was reported
to be enhanced both by B. lactis and L. rhamnosus [16].
In addition, consumption of milk fortified with prebiotic
oligosaccharide and the probiotic bacterium B. lactis was
reported to reduce episodes of dysentery, pneumonia,
and severe acute lower respiratory infection (as com-
pared to the placebo group), in 1–4 year old children,
who had limited access to hygienic conditions [17].
Although the mechanisms underlying the health pro-
moting benefits of pre/probiotics are not well under-
stood, recent in vitro research suggests that effects on
the function of intestinal epithelial cells and mucosal
immunity are important. For example, a probiotic com-
bination of Bifidobacterium spp., Lactobacillus spp., and
Streptococcus salivarius decreased the permeability of
the intestinal epithelial cells and thus increased the bar-
rier function [18]. Additionally, S. thermophilus and L.
acidophilus were shown to prevent adhesion and inva-
sion by pathogenic entero-invasive Escherichia coli and
epithelial dysfunction, accompanied by maintenance
and/or enhancement of cytoskeletal and tight junctional
protein phosphorylation [19]. Moreover, epithelial cell-
mediated immunity was induced by probiotic bacteria
such as Lactobacilli, and this immune modulatory effect
was shown to be strain specific [20].
The red seaweed Chondrus crispus (Rhodophyta) is
widely distributed in the northern Atlantic. As an eco-
nomically important seaweed species in the Atlantic
Canada region, C. crispus is also cultivated on land in
Nova Scotia, Canada. In addition to high content of total
proteins, oligopeptides and pigments, this alga is rich in
the water-soluble polysaccharide carrageenan (approxi-
mately 50-65 % on a basis of dry weight) [21, 22].
Carrageenan is widely used in the food industry as a
thickener, stabilizer and emulsifier. This high polysac-
charide content suggests that C. crispus may be a rich
source of prebiotic fiber. However, C. crispus has not yet
been investigated for its prebiotic potential. In the
current study,the prebiotic effects of cultivated C. crispus
supplemented in the feed of rats wasinvestigated. Pre-
biotic parameters such as composition and activity of
colonic microbiota, host immunity and selective metabo-




Mechanically air-dried, whole plants of a proprietary
strain of Chondrus crispus, cultivated intensively on-
land, were obtained from Acadian Seaplants Limited
(Dartmouth, Nova Scotia, Canada). The seaweed sam-
ples were finely ground and passed through a 60-mesh
sieve (0.25 mm in diameter). The fructo-oligo-saccharide
(FOS) powder, extracted from chicory roots, was pro-
vided by Cargill (Wayzata, MN), as Oliggo – Fiber™ DS2
inulin, with an average degree of polymerization less
than 10. C. crispus and FOS were mixed with a standard
basal feed (RMH 3000, LabDiet, St. Louis, MO, USA),
respectively, at the ratio of 0.0 (plus 2.5 % corn starch),
0.5 (plus 2.0 % corn starch) or 2.5 % (dry w/w). The
mixed feed was then pelleted (4.7 mm in diameter, 1.0-
1.5 cm in length) using a feed mill facility located at the
Faculty of Agriculture, Dalhousie University, Truro,
Nova Scotia. Diets were prepared just before the trial
and stored under dry and cool conditions.
Animals and sampling procedures
All animal protocols were approved by the University
Committee on Laboratory Animals at Dalhousie Univer-
sity, Canada. Male Sprague–Dawley rats (21 days old;
Charles River Laboratories Inc., Montreal, Canada) were
individually housed in standard plastic cages with a 12-
hour light–dark cycle, at 22 +/− 2 °C, with free access to
food and water. Rats were randomly assigned to each of
the five feeding groups (n = 6/group). Feed groups
consisted ofthe basal diet control group (BF), the basal
diet supplemented with 2.5 or 0.5 % (dry w/w) of culti-
vated Chondrus (C2.5 and C0.5, respectively), and the
basal diet supplemented with 2.5 or 0.5 % (dry w/w) of
FOS (F2.5 and F0.5, respectively). Environmental enrich-
ment was provided by 50 mm diameter wooden pieces
and 100 mm diameter plastic tubes. Feed intake and
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body weight for each animal were monitored weekly.
After 21 days of feeding, fresh faeces were collected.
One fecal portion was weighed immediately, dried thor-
oughly at 70 °C (for 24 h) and analyzed for moisture
content. Another fecal portion was immediately frozen
in liquid nitrogen and stored at −80 °C until further ana-
lysis. Rats were anesthetized with 3 % isoflurane, and
euthanized by blood draining through cardiac puncture.
Blood samples were collected into anticoagulant (K2-
EDTA)-coated 5-ml tubes (BD, USA), and immediately
centrifuged at 5000 × g for 15 min. The resulting plasma
was stored at −20 °C until analysis. Liver, kidney, spleen
and heart were collected, blotted on filter paper and
weighed. Colon contents from each animal were
squeezed into sterile micro-centrifuge tubes, snap-frozen
and stored at −80 °C. The colon tissue was flushed with
0.9 % NaCl, and a 0.5-cm segment, excised 1-cm from
the end of the proximal colon, was soaked in 10 % neu-
tral, buffered formalin solution (Sigma).
Immunoglobulin enzyme-linked immunosorbent assay
(ELISA)
The frozen plasma samples were thawed on ice and sub-
jected to IgA and IgG assays as previously described
[23], using the rat IgA and IgG ELISA kits, respectively
(Genway, San Diego, USA), following the manufacturer’s
instructions. Three technical replicates were performed
for each plasma sample collected. Optical density was
read on a microplate reader (BioTek) at 450 nm. A
standard curve generated from serial dilution of the rat
IgA or IgG, of a known concentration, as provided in
the kit, was used to determine the sample concentration
of IgA and IgG, respectively.
Colonic Histomorphology
After being fixed for 3 days in 10 % neutral formalin, the
proximal colon samples were paraffin embedded, sec-
tioned transversely and subjected to hematoxylin and
eosin (H&E) staining, following standard procedures
[24]. For each H&E section, at least 30 bright-field
images were captured by a Motic 2500 digital camera
(Motic, China), under 40–100 ×magnification, using an
Olympus BHS microscope (Olympus, Japan). The meas-
urement function of the Motic Images Plus 2.0 ML
software (Motic, China) was used to determine colonic
crypt depth, and the thickness of the colonic mucosa,
externa muscularis and total wall.
Bacterial DNA isolation from colon content
Bacterial DNA was extracted from 200 mg of colon
digesta using the QIAamp DNA Stool Mini Kit (Cat #
51504, Qiagen, USA) following the supplier’s instructions.
The DNA was quantified with a Nanodrop ND-2000 spec-
trophotometer (NanoDrop Technologies Wilmington,
DE), and the integrity of DNA was determined by agarose
gel electrophoresis. The DNA was stored at −20 °C until
further analysis.
Colonic microbiota profiling and analyses
Colonic microbiota analysis was carried out using Phylo-
Chip Arrays (Second Genome Inc., CA, USA). No less
than 200 ng of colonic bacterial DNA (n = 4/group) was
used as the template for bacterial 16S rRNA gene ampli-
fication. The PCR was run for 35 cycles at 95 °C for
30 sec for denaturing, 50 °C for 30 sec for annealing,
and 72 °C for 2 min for extension, using the Ex Taq sys-
tem (Takara Bio Inc., Japan). Primer sequences are as
follows: forward primer, 5´-AGRG TTTG ATCM TGGC
TCAG-3´; reverse primer, 5´-GGTT ACCT TGTT
ACGA CTT-3´. The resulting PCR product from each
sample was concentrated and quantified by electrophor-
esis using an Agilent 2100 Bioanalyzer (Agilent Tech-
nologies, CA, USA). PhyloChip Control Mix (Second
Genome Inc.) was then added to label the PCR products,
which were then fragmented, biotin labeled and hybrid-
ized to the G3 PhyloChip Array. PhyloChip arrays were
washed, stained and scanned using a GeneArray scanner
(Affymetrix, OH, USA) and each scan was captured
using the GeneChip Microarray Analysis Suite (Affyme-
trix). The hybridization score derived from the fluores-
cence intensity (FI) (the mean log2 FI × 1,000) for each
operational taxonomic unit (OTU) was used to denote
abundance. OTUs were defined by >99 % similarity of
the 16S rRNA sequence. A threshold based on perfect
match and mismatch intensities of multiple probes per
probe set [25] was used to determine the presence/ab-
sence of an OTU. Taxa-sample intersections were ana-
lyzed based on the abundance (AT) and binary matrices
(BT). The Unifrac distance metric [26] and weighted
Unifrac distance metric were used to compute the pair-
wise BT and AT dissimilarity scores; the weighted
Unifrac metric reflects the abundance of and the phylo-
genetic distance between OTUs. Hierarchical clustering
via average-neighbor (HC-AN) and principal coordinate
analysis (PCA) were used to graphically summarize
inter-sample relationships on the basis of AT and BT
dissimilarity scores. Thereafter, we analyzed the abun-
dance data and identified the taxa which showed signifi-
cant/greatest changes between the control and the
treated groups.
Gas chromatography analysis of short chain fatty acids
(SCFAs)
The gut microbial metabolites, SCFAs, in rat faecal sam-
ples were quantified by gas chromatography (GC)
following a previously described protocol [27], with modi-
fications. A Bruker 430-GC system (Billerica, MA, USA),
equipped with a flame ionization detector (FID) and an
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automatic liquid sampler, was used. A J&W DB-FFAP
capillary column (Agilent Technologies Inc., USA; Part #
J125-3232, 30 m × 0.53 mm× 1-μm film thickness) was
used. An aliquot of 0.2 g of faeces, which was previously
frozen and thawed on ice, was homogenized in 2 ml of
extraction buffer (0.1 % (w/v) HgCl2 and 1 % (v/v) H3PO4)
containing 0.045 g/l of 2-ethylbutyric acid (Sigma) as an
internal standard. The resulting slurry was centrifuged,
prior to the supernatant being passed through a 0.2 μm
filter. The injection volume was 0.5 μl. Each sample run
was preceded with a wash run of 1 % formic acid. The
oven temperature was held at 80 °C for 1.2 min, then
increased to 200 °C at 10 °C /min and held for 5 min. The
temperature for the FID and the injection port was 220 °C
and 180 °C, respectively. The flow rate of helium, hydro-
gen, and air was 25, 30, and 300 ml/min, respectively. Spe-
cific SCFAs were identified by running an external volatile
acid standard mix (Supelco, USA). The concentration of
SCFAs was quantified by running the internal standard
and the external standard mix, as previously described
[28]. All reagents were of GC grade and solutions were
prepared with deionized water.
Statistics
The statistical analyses were performed using SPSS 15.0
(SPSS, USA). Data were presented as the mean ± SD or
SE. Differences between the control group and the diet-
ary supplemented groups were assessed using one-way
ANOVA followed by the independent two-tailed t test
or the Mann–Whitney test. Differences were considered
as significant when p < 0.05.
Results
Effect of diets on body weight, organ weight, faecal
moisture, and host immunity
Dietary supplementation with either cultivated red sea-
weed C. crispus or FOS did not affect rat body weight
gain (Fig. 1a). There was also no effect on the weight of
organs such as kidney, heart and spleen (Additional file
1). Although there was a minor increase in the weight of
liver in all fiber-supplemented groups, the change was
not statistically significant (Fig. 1b) as compared to the
control rats.The C. crispus supplemented diet C2.5 in-
creased faecal moisture after 21 days of feeding (in-
creased by 17 % (p = 0.04)), as compared to the control
Fig. 1 Effect of diets on body weight gain, liver weight, faecal moisture, and plasma immunoglobulin. Body weight (a) was monitored weekly
during the feeding period. Liver weight (b) and faecal moisture (c) were determined after 3 weeks of feeding. Data are presented as the mean ±
SD (n = 6). At the end of the feeding period, IgA (d) and IgG (e) levels in rat plasma samples were determined by ELISA and are presented as the
mean ± SD, with three biological replicates and two technical replicates. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 = FOS
Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %. *p < 0.05; **p < 0.01 (versus BF)
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group (Fig. 1c). The C0.5, F0.5 andF2.5 diets did show a
slight increase in faecal moisture, but it was not statisti-
cally significant.
Based on our previous observations on the immune-
modulation effect of C. crispus [29], immunoglobulin
levels in rats were expected to be influenced by dietary C.
crispus. The IgA level in the C0.5 group (143 μg/ml)
increased 2-fold, as compared to the control group (p =
0.006) (Fig. 1d). Likewise, the IgG level in the C0.5 group
increased 1.6-fold over the the control group (p = 0.02)
(Fig. 1e). Thus, both IgA and IgG levels were significantly
elevated in the group fed with the lower rate of C. crispus
(C0.5), as compared to the basal feed group (Fig. 1).
Effect of diets on the overall composition of colonic
microbiota
Ingestion of non-digestible carbohydrates can differen-
tially stimulate the growth of colonic bacterial groups
[2]. Therefore, colonic microbiota profiling was used to
investigate the prebiotic potential of non-starch,
polysaccharide-rich, cultivated C. crispus. Through prin-
cipal component analysis (PCA), a general differentiation
between the supplemented diets and the control diet
was evident (Fig. 2a). Larger variation from the basal
feed group indicated greater dissimilarity. Additionally,
the HC-AN analysis based on weighed Unifrac distance
showed differential hierarchical clustering between the
control group and the supplemented groups, especially
for the C0.5 group (Fig. 2b).
Effect of diets on the taxonomic composition of colonic
microbiota
Although colonic microbiota community composition was
affected by diet (Fig. 2), its composition remains stable at
the higher taxonomic levels of phylum and family, among
the various diet groups. At the phylum level, the Firmi-
cutes, Bacteroidetes and Proteobacteria predominated in
the gut for all diet groups, accounting for 52.37 %,
24.25 %, and 10.2 %, respectively (Fig. 3). For each diet
group, either control or supplemented, the ten most
abundant families (Lachnospiraceae, Ruminococcaceae,
RikenellaceaeII, Lactobacillaceae, Enterobacteriaceae, Pre-
votellaceae, Bacteroidaceae, Porphyromonadaceae, unclas-
sified (Cyanobacteria) and Clostridiaceae) collectively
account for an average of 81 % of the colonic microbiota.
The microbiota family composition was not significantly
affected by either diet (Fig. 4). At the genus level, the
abundance of the identified genera was shifted differen-
tially by the C. crispus- or FOS-supplemented diets (see
Tables 1 and 2). With the C2.5 diet, there were abundance
Fig. 2 Effect of diets on the structure and composition of the colonic microbiome. a PCA analysis based on weighted Unifrac distance among
the samples of 906 taxa with significant abundance differences across at least one of the groups. PCA1, 54 % of variation; PCA2, 11 % of variation.
Larger variation from the basal feed group represents greater dissimilarity. b HC-AN analysis of hierachical clustering based on weighed Unifrac
distance between samples given abundance of 906 taxa present in at least one of the samples. In the dentrogram, components clustering with
greater distance shows greater dissimilarity. PCA, principal component analysis. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %;
F2.5 = FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %
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increases in 7 genera, including Bifidobacterium (p =
0.001), Legionella (p < 0.0001), Sutterella (p = 0.001), Blau-
tia (p = 0.004), Holdemania (p = 0.032), Shewanella (p =
0.01) and Agarivorans (p = 0.005), together with a decrease
in the abundance of the genus Streptococcus (p = 0.046), as
compared to the control (Table 1). The C0.5 group
showed no significant changes in these genera compared
to the control. Dietary supplementation with 2.5 % FOS
(F2.5) resulted in abundance shifts in a different set of
genera (Table 2). For example, both F2.5 and F0.5 groups
showed increased Actinetobacter (p = 0.011, 0.006, re-
spectively) and Pseudomonas (p = 0.017, 0.012, respect-
ively). In addition, the F2.5 diet was associated with
increases in the community of Alicyclobacillus (p = 0.009)
and Bacillus (p = 0.045), together with a decreased abun-
dance of Coprococcus (p = 0.009) (Table 2).
Among the identified species of colonic bacteria, diet
affected the abundance of some beneficial, as well as
pathogenic species (Fig. 5). Specifically, as compared to
the control group, there was a 4.9-fold and 2.2-fold in-
crease in the abundance of the well-established probiotic
bacterium, Bifidobacterium breve, in the C2.5 (p = 0.001)
and C0.5 (p = 0.15) groups. On the other hand, the F2.5
and F0.5 groups showed less enhanced abundance (p =
0.349, and 0.533, respectively) of B. breve (Fig. 5). Hence,
the influence of C. crispus and FOS on the colonic B.
breve community showed a dose-dependency, with the
higher concentration associated with a greater abundance
Fig. 3 Effect of diets on colonic microbiota composition at the phylum level. Proportions of various phyla are shown as percentage of the total
abundance of microbiota. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 = FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %
Fig. 4 Effect of diets on colonic microbiota composition at the family level. Proportions of the top ten richest taxa at the family rank are shown
as percentage of the total abundance of microbiota. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 = FOS Inulin 2.5 %; F0.5 =
FOS Inulin 0.5 %
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of B. breve. In contrast, the potentially-pathogenic species,
Clostridium septicum and Streptococcus pneumoniae de-
creased slightly, in C2.5, C0.5, and F0.5 groups although
these decreases with not statistically significant (Fig. 5).
Effect of diets on the gut microbial metabolites
Short chain fatty acids (SCFAs) are the main metabolic
products of anaerobic bacteria in the GI tract [30]. There-
fore, the abundance of intestinal SCFAs indicates the
metabolic activity of anaerobic gut bacteria. To investigate
the influence of diet on metabolic activity of the gut
microbiota, fresh feacal samples from each feeding group
were collected, and SCFAs were quantified by GC-FID.
Despite their fluctuating abundance among various diet
groups, acetic, propionic and butyric acids were found to
predominate in all diet groups (Fig. 6). In the C2.5 group,
the concentration of these SCFA species increased signifi-
cantly by 1.4-, 1.3-, and 2.1-fold, respectively as compared
to the control group (p = 0.001, 0.04, and 0.01, respect-
ively; Fig. 6). Similarly, acetic and butyric acids signifi-
cantly increased in the C0.5 group (p = 0.02, 0.03, vs.
control, respectively), and the concentration of propionic,
n-valeric, iso-butyric, and iso-valeric acids were not
significantly affected, as compared to the control (Fig. 6).
The total amount of all the tested species of SCFAs was
significantly elevated in the C2.5 and C0.5 groups. The
concentrations of acetic, butyric, and total acids showed a
slight, but not significant, increase in the F2.5 or F0.5
group, as compared to the control (Fig. 6).
Effects of diets on colonic histo-morphology
After 3 weeks of dietary supplementation with C. crispus,
the proximal colon of the young rats showed significant
histological changes, as revealed by H&E staining of trans-
verse sections. Dietary supplementation with C. crispus at
both concentrations resulted in a significant increase in
the observed depths of the colonic crypt, mucosa, externa
muscularis and colonic total wall (p < 0.05 in all cases),
with C0.5 outperforming C2.5 overall (Fig. 7). The C0.5
treatment group, showed increases of 31 %, 33 %, 62.9 %
and 38.6 % in these parameters, respectively compared to
the control group. The FOS treatment groups (F2.5 and
F0.5) also showed significant histo-morphological changes,
Table 1 The 20 colonic bacterial genera with the greatest increase or decrease in abundance in rats fed a seaweed-supplemented
diet (C2.5), and their abundance in other diet supplemented groups. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %;
F2.5 = FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %
Phylum Class Order Family Genus Fold changea
C2.5 C0.5 F2.5 F0.5
Proteobacteria Alphaproteobacteria Rhizobiales Aurantimonadaceae Aurantimonas 11.7 12.5 4.7 7.8
Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium 4.8 1.1 2 1.6
Proteobacteria Gammaproteobacteria Alteromonadales Alteromonadaceae Agarivorans 3.2 1.8 1.5 −1.8
Proteobacteria Gammaproteobacteria Legionellales Legionellaceae Legionella 2.9 2 2 1.3
Proteobacteria Gammaproteobacteria Alteromonadales Shewanellaceae Shewanella 2.6 1.5 −1.3 −1.9
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia 2.4 1.6 2.3 −2.5
Proteobacteria Betaproteobacteria Burkholderiales Alcaligenaceae Sutterella 2.0 1.6 2.4 1.1
Tenericutes Erysipelotrichi Erysipelotrichales Erysipelotrichaceae Holdemania 1.8 1.5 2.4 1.1
Firmicutes Clostridia Clostridiales Lachnospiraceae Dorea 1.6 1.1 −1.1 −1.2
Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus 1.4 1.1 1.3 1.2
Actinobacteria Actinobacteria Actinomycetales Micrococcaceae Arthrobacter −1.2 −1.1 −1.1 −1.2
Firmicutes Clostridia Clostridiales Lachnospiraceae Oribacterium −1.3 1.0 −2.3 −2.0
Proteobacteria Alphaproteobacteria Rhodobacterales Rhodobacteraceae Thioclava −1.4 −1.0 −2.6 −2.8
Actinobacteria Actinobacteria Actinomycetales Micrococcaceae Micrococcus −1.6 −1.5 −1.3 −1.8
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus −1.9 −1.3 −1.3 −1.4
Actinobacteria Actinobacteria Actinomycetales Intrasporangiaceae Janibacter −2.0 1.2 −4.0 −1.2
Tenericutes Mollicutes Entomoplasmatales Spiroplasmataceae Spiroplasma −2.1 −1.5 −1.5 1.2
Firmicutes Clostridia Clostridiales Lachnospiraceae Pseudobutyrivibrio −2.3 −6.4 −1.3 1.1
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Proteus −5.9 −1.3 1.6 1.0
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae SMC −24.4 −1.4 1.8 −1.0
aFold change represents the relative abundance of the bacterial genus in rats fed seaweed- or inulin-supplemented diets compared with the basal diet; values
were calculated from the microarray hybridization scores derived from fluorescence intensity. C2.5, Chondrus crispus 2.5 % (dry w/w); C0.5, 0.5 %; F2.5, FOS inulin
2.5 %; F0.5, 0.5 %
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Table 2 The 20 colonic bacterial genera with greatest increase or decrease in abundance in rats fed a FOS inulin-supplemented diet
(F2.5), and their abundance in other diet supplemented groups. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 =
FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %
Phylum Class Order Family Genus Fold changea
C2.5 C0.5 F2.5 F0.5
Proteobacteria Alphaproteobacteria Rhizobiales Aurantimonadaceae Aurantimonas 11.7 12.5 4.7 7.8
Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium 4.8 2.1 2.9 1.6
Firmicutes Clostridia Clostridiales Lachnospiraceae Blautia 2.4 1.5 2.3 −2.5
Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae Acinetobacter −1.1 1.2 2.1 2.7
Proteobacteria Gammaproteobacteria Legionellales Legionellaceae Legionella 2.9 2.0 2.0 1.3
Tenericutes Mollicutes Entomoplasmatales Entomoplasmataceae Mesoplasma 1.3 1.4 1.9 1.8
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae SMC −24.4 −1.4 1.8 1.0
Proteobacteria Gammaproteobacteria Enterobacteriales Enterobacteriaceae Proteus −5.9 −1.3 1.6 1.0
Chloroflexi Anaerolineae Anaerolineales Anaerolinaceae Anaerolinea 1.3 1.2 1.6 1.0
Chlamydiae Chlamydiae Chlamydiales Parachlamydiaceae Parachlamydia 1.2 1.5 1.6 −1.1
Firmicutes Clostridia Clostridiales Ruminococcaceae Oscillospira 1.2 1.0 −1.3 −1.3
Proteobacteria Gammaproteobacteria Alteromonadales Shewanellaceae Shewanella 2.6 1.5 −1.3 −1.9
Firmicutes Clostridia Clostridiales Lachnospiraceae Pseudobutyrivibrio −2.3 −6.4 −1.3 1.1
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus −1.9 −1.3 −1.3 −1.4
Firmicutes Clostridia Clostridiales Ruminococcaceae Ruminococcus 1.0 1.1 −1.3 1.0
Tenericutes Mollicutes Entomoplasmatales Spiroplasmataceae Spiroplasma −2.1 −1.5 −1.5 1.2
Proteobacteria Alphaproteobacteria Rhizobiales Rhizobiaceae Rhizobium 1.0 1.1 −2.0 −1.9
Firmicutes Clostridia Clostridiales Lachnospiraceae Oribacterium −1.3 1.0 −2.3 −2.0
Proteobacteria Alphaproteobacteria Rhodobacterales Rhodobacteraceae Thioclava −1.4 1.0 −2.6 −2.8
Actinobacteria Actinobacteria Actinomycetales Intrasporangiaceae Janibacter −2.0 1.1 −4.0 −1.2
aFold change represents the relative abundance of the bacterial genus in rats fed seaweed- or inulin-supplemented diets compared with the basal diet; values
were calculated from the microarray hybridization scores derived from fluorescence intensity. C2.5, Chondrus crispus 2.5 % (dry w/w); C0.5, 0.5 %; F2.5, FOS inulin
2.5 %; F0.5, 0.5 %
Fig. 5 Effect of diets on the abundance of species of beneficial or pathogenic potential from the colonic microbiota. Relative abundance of the
species was calculated by the fluorescence intensity (FI) derived from microarray hybridization scores. BF = basal feed; C2.5 = C. crispus 2.5 %;
C0.5 = C. crispus 0.5 %; F2.5 = FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %. Data are presented as mean ± SE. **p < 0.01 (versus BF)
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although the effects were not as great as in the C0.5 group
(Fig. 7).
Discussion
The cultivated red seaweed C. crispus contains 50-65 %
(on a basis of dry weight) of carrageenan, a sulfated
polysaccharide [22]. Like many other dietary fibers,
carrageenan is not digested in the upper GI tract and
passes through to the large intestine, where it is fermen-
ted and utilized by colonic microbiota. In this study, we
used a Phylochip assay to monitor colonic microbiota
changes resulting from diet supplementation with C.
cripsus. Phylochip is a comprehensive method to study
the microbial communities by using a 16S rRNA gene
Fig. 6 Effect of diets on faecal SCFA concentrations. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 = FOS Inulin 2.5 %; F0.5 =
FOS Inulin 0.5 %. SCFA = short chain fatty acid. Data are presented as the mean ± SE. *p < 0.05; **p < 0.01 (versus BF)
Fig. 7 Effect of diets on the histology of rat proximal colon. Shown were changes in the depth of colonic crypt (a) mucosa (b) externa muscularis
(c) and total wall (d). BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 = FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %. Data are
presented as the mean ± SD. *p < 0.05; **p < 0.01 (versus BF)
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DNA microarray [31]. Besides being relatively simple and
sensitive, Phylochip assay has a major advantage over
high-throughput sequencing in that it detects both the
presence and the abundance of individual species or other
operational taxonomic units (OTUs) [32, 33]. Increases in
some beneficial colonic microbiota were observed with C.
crispus supplementation, such as the well-known probiotic
bacterium, Bifidobacterium breve. Its increased abundance
may have been caused by an enrichment of fermentable
substrates as a result of C. crispus supplementation. Previ-
ous investigations with rats have shown that supplementa-
tion of digestion-resistant raffinose in a high-sucrose diet
was associated with increased populations of certain spe-
cies of Bifidobacterium [34]. Many other bacterial genera,
such as Legionella, Sutterella, Blautia, Holdemania, She-
wanella and Agarivorans were also enhanced with C. crip-
sus supplementation. Likewise, microbial decreases were
observed in the genus Streptococcus. C. crispus fiber (car-
rageenan) may have been acting as a fermentable substra-
tefor the probiotic bacteria present in the GI tract, thus
promoting the growth of the probiotic groups. Further,
the probiotics may have outcompeted certain groups of
pathogenic bacteria [3]. It is possible that bacterial groups
were introduced to the GI tract directly from the surfaces
of the seaweed itself (epiphytic/endophytic seaweed bac-
terial groups), contributing to changes seen in some of the
GI tract bacterial communities. However, the microbiota
associated with the seaweed remains to be characterized.
The relevance of GI tract bacterial community structure
on the health of treated rats remains uncertain, because
each genus usually consists of multiple species with di-
verse community functions. The increase in Bifidobacter-
ium breve abundance in C. crispus fed rats may be
associated with beneficial effects, such as immune modu-
lation [9, 16], improvement of consistency and frequency
of the stool [4] and prevention of allergic diseases [9, 15].
Other C. crispus compounds, including proteins, peptides,
lipids, and pigments can also partially contribute to the
health of the colon, however these may largely be metabo-
lized in the upper GI tract. Except for Bifidobacterium
and a few other genera, the abundance of the majority of
the 906 OTUs were not markedly affected by either the
seaweed or the FOS diet. This is expected since the rats
were fed a balanced basal diet and were housed as un-
stressed test subjects in this current study. Bacterial select-
iveness for fermentation substrates [2, 3] can also explain
why only a few groups were shifted in relative abundance
with C. crispus supplementation. Though this experiment
was conducted over just 21 days, previous studies have
shown 15–21 days of feed intervention to be sufficient to
influence colonic microbiota [34, 35]. Besides facilitating
favorable changes in gut microbiota, dietary supplementa-
tion with cultivated C. crispus may also play a role in
regulation of pathogenic microbial activity. It has been
previously shown that water extracts of this cultivated C.
crispus also suppressed quorum sensing and the production
of virulence factors of the pathogenic bacterium Pseudo-
monas aeruginosa [29]. This selective anti-pathogenic effect
may further account for the health benefits in rats with
dietary supplementation with cultivated C. crispus.
Although the overall composition of the colonic micro-
flora was not altered at the family and phylum levels by C.
crispus supplementation, a significant increase in the
activity of the gut microflora was suggested by the ele-
vated SCFA concentrations recorded in the faecal samples.
Possible explanations include: 1) the enhanced metabol-
ism of specific microbial groups, capable of utilizing C.
crispus fiber as a substrate for probiotic fermentation,
resulted in a competitive advantage for these probiotic
groups; 2) unmeasured or unclassified microbial groups
were able to utilize fermentable C. crispus fiber as a sub-
strate for growth.=; 3) the increased abundance of B. breve
(Fig. 5) may have made a significant contribution to the
elevated SCFA concentrations, especially for acetate since
this is the major fermentation product of B. breve [36]; 4)
the fermentation by multiple identified OTUs, whose
abundance was enhanced but not to a statistically signifi-
cant extent, collectively resulted in a pronounced increase
in the concentrations of some species and/or the total
SCFAs. The major types of gut SCFAs recorded were
acetic, propionic and butyric acids [37]. These SCFA’s are
reported to have very diverse physiological functions. Bu-
tyric acid was shown to be more readily utilized by the
colonic epithelial cells than acetic and proprionic acids,
glucose and other substrates. Furthermore, butyric acid
affects the proliferation and differentiation of colon- and
intestine-derived cells; it is consequently important for the
health of colonocytes and mucosa [38]. Butyric acid was
shown to reduce the incidence and the size of colitis-
related tumors in rats [39], which suggests an immune-
modulating function of butyrate. All of the three major
SCFAs were recently shown to play a role in host-immune
regulation. When acetic, propionic or butyric acid was
individually, or collectively, supplemented to the diet,
germ-free mice showed selective increases in the abun-
dance and functions of the colonic Treg cells, which s-
uppressed inflammation [40]. In the current study, higher
concentrations of fecal SCFAs were measured in both the
2.5 % and 0.5 % seaweed supplemented groups, but not in
the FOS-supplemented animals. The plasma immuno-
globulin IgA and IgG levels were elevated in the C0.5
supplemented group. The C2.5 group shown no such ele-
vation of IgA or IgG. Also colonic histo-morphological
parameters were improved to a lesser extent in the C2.5
group than in the C0.5 group (as compared to the
control). There is a possibility of decreased absorption of
SCFAs by the colonocytes with higher concentrations of
dietary C. crispus (C2.5 group), due to the high content of
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water soluble polysaccharide and its gel-forming proper-
ties [41], as shown by the increased faecal moisture
content recorded in this group.
In addition to colonic epithelial cells, SCFAs are read-
ily absorbed and metabolized in the liver [42]. The up-
take of acetic acid by the liver was shown to be
enhanced when the supply increased.It has also been
reported that butyric acid uptake by the liver was higher
than that of propionic acid. Both fatty acids were metab-
olized and thus barely detectable in the liver under nor-
mal physiological conditions [42]. An increased supply
of SCFAs in the gut may contribute to an increase in
liver weight. This may explain the finding that liver
weight was slightly, but not significantly, increased in C.
crispus-supplemented rats (Fig. 1b). It suggests that a
larger amount of SCFAs was produced and utilized by
the liver, as compared to the control animals. The over-
all health status of the animals was not negatively af-
fected by dietary supplementation of 0.5 % or 2.5 % of C.
crispus or FOS as shown by feed intake (Additional file
2) and the clinical pathology assay of plasma samples
prepared from cardiac blood (Additional file 3).
A significant improvement in the colonic morphology
of young rats was recorded when fed a diet supple-
mented with C. crispus for 21 days. Andriamihaja et al.
[35] found that the morphology of colon epithelial cells
was markedly modified in rats after they were fed a
high-protein diet for 15 days, which was associated with
changes in the abundance of colonic SCFAs, such as
propionic and valeric acids, but not acetic and butyric
acids. Our observation of elevated faecal moisture con-
tent in rats supplemented with 2.5 % C. crispus may be
related to increased growth of colonic mucosa. Indeed,
the dietary bulk content (as reflected by the moisture
content of digesta or faeces) tended to positively correl-
ate with colonic mucosal growth (as revealed by colonic
mucosal DNA synthesis) [43]. In this study, weaning
rats in the rapid growth phase were used. This rapid
growth may have further contributed to the dramatic
changes in the gut morphology in response to dietary
supplementation with C. crispus.
Conclusions
The results of the rat trial presented here suggest a
number of beneficial effects from dietary supplementa-
tion with cultivated C. crispus. Increased abundance of
beneficial colonic microbiota with a concomitant de-
crease in pathogenic microbes was observed. Further, C.
crispus supplementation resulted in an increase in the
concentration of SCFAs, promoted colonic growth and
elevated immunoglobulin levels. Thus, cultivated C. cris-
pus shows promise as a functional food due to its pre-
biotic effects.
Additional files
Additional file 1: Effect of diets on the weight of kidney, spleen,
and heart. BF = basal feed; C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %;
F2.5 = FOS Inulin 2.5 %; F0.5 = FOS Inulin 0.5 %. Data are presented as the
mean ± SD. P > 0.05 (versus BF). (DOC 38 kb)
Additional file 2: Effect of diets on feed intake. BF = basal feed;
C2.5 = C. crispus 2.5 %; C0.5 = C. crispus 0.5 %; F2.5 = FOS Inulin 2.5 %;
F0.5 = FOS Inulin 0.5 %. Data are presented as the mean ± SD. P > 0.05
(versus BF). (DOC 38 kb)
Additional file 3: Effect of diets on blood clinical biochemistry in
rats. (DOC 54 kb)
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